# Notice of Intent to Sole Source

Canonical: https://abierto.us/opportunities/fda1284766

- Solicitation number: FDA-1284766
- Notice type: Special notice
- Status: Closed. Deadline was June 16, 2025 at 3:00 PM EDT
- Department: Department of Health and Human Services
- Contracting office: Department of Health and Human Services (n-HEALTHANDHUMANSERVICESDEPARTMENTOF)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: June 5, 2025
- Last posted: June 5, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/2d472891df0849d8a95445c03c94ee7d/view

## Description

The objective of the contract is to obtain Human Induced Pluripotent Stem Cell-Derived Cells. These cells will provide the FDA with the required material to support MPS studies. The cells will enable scientific capabilities consistent with the mission of the Center for Drug Evaluation and Research (CDER).

## Publications

- June 5, 2025: Special notice, due June 16, 2025 at 3:00 PM EDT. Notice 2d472891df0849d8a95445c03c94ee7d. https://sam.gov/workspace/contract/opp/2d472891df0849d8a95445c03c94ee7d/view

## Points of contact

- Rodney D. Aytch, rodney.aytch@fda.hhs.gov, 2404027514

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fda1284766.